TITLE

HIGHLIGHTS OF THIS ISSUE

PUB. DATE
July 2006
SOURCE
CMAJ: Canadian Medical Association Journal;7/4/2006, Vol. 175 Issue 1, p13
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This section introduces several articles within the issue of the Canadian Medical Association Journal, including one paper discussing evidence concerning the effect of exercise on breast cancer patients and survivors and another paper which reported on the approved use of parathyroid hormone for the treatment of osteoporosis.
ACCESSION #
21376594

 

Related Articles

  • Parathyroid hormone related protein and hypercalcaemia in breast cancer. Bundred, N.J.; Ratcliffe, Wendy A.; Walker, Rosemary A.; Coley, S.; Morrison, J.M.; Ratcliffe, J.G. // BMJ: British Medical Journal (International Edition);12/14/91, Vol. 303 Issue 6816, p1506 

    Examines the role of parathyroid hormone related protein of hypercacaemia in women with breast cancer. Determination of the plasma concentrations and tumor expression of parathyroid hormone related protein; Measurement on the bone metastases and serum calcium concentration of women; Pattern of...

  • Parathyroid Hormone-Related Protein Production by Breast Cancers, Improved Survival, and Reduced.... Henderson, Michael A.; Danks, Janine A. // JNCI: Journal of the National Cancer Institute;02/07/2001, Vol. 93 Issue 3, p234 

    Investigates the relationship among detection of parathyroid hormone-related protein (PTHrP) in primary breast cancers, development of skeletal complications, and overall survival. Localization of the PTHrP in female breast tumors; Association of PTHrP production with a less invasive phenotype;...

  • Serum calcium and breast cancer risk: results from a prospective cohort study of 7,847 women. Martin Almquist; Jonas Manjer; Lennart Bondeson; Anne-Greth Bondeson // Cancer Causes & Control;Aug2007, Vol. 18 Issue 6, p595 

    Abstract  Experimental and epidemiological studies suggest that calcium-regulating hormones—parathyroid hormone (PTH) and vitamin D—may be associated with breast cancer risk. No prospective cohort study has investigated the association between pre-diagnostic calcium levels...

  • Type 1 receptor parathyroid hormone (PTH1R) influences breast cancer cell proliferation and apoptosis induced by high levels of glucose. Liang, Huasheng; Zhong, Yuhua; Huang, Yu; Chen, Genben // Medical Oncology;Jun2012, Vol. 29 Issue 2, p439 

    Increased breast cancer incidence parallels the increase in cases of type 2 diabetes. We investigated the effect of type 1 receptor parathyroid hormone (PTH1R) expression on viability and apoptosis of breast cancer cells exposed to high levels of glucose. Upregulation of PTH1R was detected in...

  • The parathyroid hormone-related protein receptor is expressed in breast cancer bone metastases and promotes autocrine proliferation in breast carcinoma cells. Hoey, R P; Sanderson, C; Iddon, J; Brady, G; Bundred, N J; Anderson, N G // British Journal of Cancer;2/24/2003, Vol. 88 Issue 4, p567 

    Overproduction of parathyroid hormone-related protein (PTHRP) occurs in a high proportion of primary breast cancers (PBC) and is strongly implicated in their metastatic spread to bone. Although the PTHRP-receptor (PTHRP-R) is often coexpressed with PTHRP in PBC, its role in regulating breast...

  • Co-expression of parathyroid hormone related protein and TGF-beta in breast cancer predicts poor survival outcome. Cheng Xu; Zhengyuan Wang; Rongrong Cui; Hongyu He; Xiaoyan Lin; Yuan Sheng; Hongwei Zhang; Xu, Cheng; Wang, Zhengyuan; Cui, Rongrong; He, Hongyu; Lin, Xiaoyan; Sheng, Yuan; Zhang, Hongwei // BMC Cancer;11/23/2015, Vol. 15, p1 

    Background: Better methods to predict prognosis can play a supplementary role in administering individualized treatment for breast cancer patients. Altered expressions of PTHrP and TGF-β have been observed in various types of human cancers. The objective of the current study was...

  • Level of Expression of Parathyroid Hormone Related Protein and its Receptor in Human Breast Cancer and its Correlation with the Clinical Outcome. Zia, Mohammad K.; Rmali, Khaled A.; Mansel, Robert E.; Jiang, Wen G. // International Journal of Cancer Research;2007, Vol. 3 Issue 2, p92 

    In this study we examined the level of the expression of PTHrP and its receptor (PTHrP-R) in human breast cancer and correlated their level of expression with the clinical outcome. Primary Breast cancer samples (n = 124) and adjacent non-cancerous breast tissues obtained from patients in cohort...

  • Immunity in Atherosclerosis: It's Not All Bad. Breindl, Anette // BioWorld Today;11/14/2011, Vol. 22 Issue 221, Special section p1 

    This section offers news briefs relating to biotechnology research. A population of dendritic cells which protect against the development of cardiovascular disease was identified by researchers from the Korean Ewha Women's University. A study by Canadian McGill University has found various ways...

  • Reply: PTHrP on MCF-7 breast cancer cells: a growth factor or an antimitogenic peptide? Hoey, R. P.; Sanderson, C.; Iddon, J.; Brady, G.; Bundred, N. J.; Anderson, N. G. // British Journal of Cancer;3/22/2004, Vol. 90 Issue 6, p1295 

    Focuses on parathyroid hormone-related proteins (PTHrP) on malignant catarrhal fever (MCF)-7 breast cancer cells. Investigation on the actions of PTHrP in MCF-7 cells; Dose-responsiveness of MCF-7 calls to PTHrP; Contentions for the function between a growth factor and antimitogenic peptide.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics